DES or BMS in acute myocardial infarction?
- PMID: 17959622
- DOI: 10.1093/eurheartj/ehm474
DES or BMS in acute myocardial infarction?
Comment on
-
Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction.Eur Heart J. 2007 Nov;28(22):2706-13. doi: 10.1093/eurheartj/ehm402. Epub 2007 Sep 27. Eur Heart J. 2007. PMID: 17901079 Review.
Similar articles
-
A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.J Cardiovasc Med (Hagerstown). 2009 Feb;10(2):192-9. doi: 10.2459/JCM.0b013e32831f9176. J Cardiovasc Med (Hagerstown). 2009. PMID: 19377384 Clinical Trial.
-
Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry.J Cardiovasc Med (Hagerstown). 2009 Apr;10(4):322-9. doi: 10.2459/JCM.0b013e3283276ebb. J Cardiovasc Med (Hagerstown). 2009. PMID: 19430343
-
Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.Int J Cardiol. 2009 Apr 3;133(2):213-22. doi: 10.1016/j.ijcard.2007.12.040. Epub 2008 Apr 3. Int J Cardiol. 2009. PMID: 18394731
-
Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials.Catheter Cardiovasc Interv. 2009 Aug 1;74(2):323-32. doi: 10.1002/ccd.22017. Catheter Cardiovasc Interv. 2009. PMID: 19360858 Review.
-
Off-label use of stents: bare-metal versus drug-eluting stents.Expert Rev Cardiovasc Ther. 2008 Sep;6(8):1095-106. doi: 10.1586/14779072.6.8.1095. Expert Rev Cardiovasc Ther. 2008. PMID: 18793112 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical